Soligenix
SNGX
#10224
Rank
ยฃ11.69 M
Marketcap
ยฃ1.16
Share price
-6.06%
Change (1 day)
-52.01%
Change (1 year)

EPS for Soligenix (SNGX)

EPS in 2025 (TTM): -ยฃ2.43

According to Soligenix's latest financial reports the company's current EPS (TTM) is -ยฃ2.42. In 2024 the company made an earnings per share (EPS) of -ยฃ3.72 an increase over its 2023 EPS that were of -ยฃ9.47.

EPS history for Soligenix from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ2.43-34.69%
2024-ยฃ3.72-60.66%
2023-ยฃ9.47-83.55%
2022-ยฃ57.5513.95%
2021-ยฃ50.50-56.03%
2020-ยฃ114.8633.33%
2019-ยฃ86.15-29.41%
2018-ยฃ122.04-41.38%
2017-ยฃ208.1924.73%
2016-ยฃ166.91-69%
2015-ยฃ538.42-6.25%
2014-ยฃ574.31-50.77%
2013-ยฃ1,16775.68%
2012-ยฃ664.0568.18%
2011-ยฃ394.84-69.86%
2010-ยฃ1,310-8.75%
2009-ยฃ1,43633.33%
2008-ยฃ1,077-57.14%
2007-ยฃ2,513-46.15%
2006-ยฃ4,66644.44%
2005-ยฃ3,230-40.7%
2004-ยฃ5,448-15.62%
2003-ยฃ6,457-25.52%
2002-ยฃ8,669-80.94%
2001-ยฃ45,482160.89%
2000-ยฃ17,433-40.57%
1999-ยฃ29,333-63.84%
1998-ยฃ81,121601.73%
1997-ยฃ11,560101.7%
1996-ยฃ5,731

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Emergent BioSolutions
EBS
ยฃ1.05-143.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ2.77-214.37%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
ยฃ1.29-153.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ7.81-422.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ1.52-37.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ0.71-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.47-119.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel